Cargando…

Current treatment options for the management of esophageal cancer

In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawhinney, Mark R, Glasgow, Robert E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496368/
https://www.ncbi.nlm.nih.gov/pubmed/23152702
http://dx.doi.org/10.2147/CMAR.S27593
_version_ 1782249620872626176
author Mawhinney, Mark R
Glasgow, Robert E
author_facet Mawhinney, Mark R
Glasgow, Robert E
author_sort Mawhinney, Mark R
collection PubMed
description In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors influencing outcome has also been developed. This has led to more management options for esophageal cancer at all stages than ever before. A multidisciplinary, team approach to management in a high volume center is the preferred approach. Each patient should be individually assessed based on type of cancer, local or regional involvement, and his or her own functional status to determine an appropriate treatment regimen. This review will discuss management of esophageal cancer relative to disease progression and patient functional status.
format Online
Article
Text
id pubmed-3496368
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-34963682012-11-14 Current treatment options for the management of esophageal cancer Mawhinney, Mark R Glasgow, Robert E Cancer Manag Res Review In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors influencing outcome has also been developed. This has led to more management options for esophageal cancer at all stages than ever before. A multidisciplinary, team approach to management in a high volume center is the preferred approach. Each patient should be individually assessed based on type of cancer, local or regional involvement, and his or her own functional status to determine an appropriate treatment regimen. This review will discuss management of esophageal cancer relative to disease progression and patient functional status. Dove Medical Press 2012-11-02 /pmc/articles/PMC3496368/ /pubmed/23152702 http://dx.doi.org/10.2147/CMAR.S27593 Text en © 2012 Mawhinney and Glasgow, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Mawhinney, Mark R
Glasgow, Robert E
Current treatment options for the management of esophageal cancer
title Current treatment options for the management of esophageal cancer
title_full Current treatment options for the management of esophageal cancer
title_fullStr Current treatment options for the management of esophageal cancer
title_full_unstemmed Current treatment options for the management of esophageal cancer
title_short Current treatment options for the management of esophageal cancer
title_sort current treatment options for the management of esophageal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496368/
https://www.ncbi.nlm.nih.gov/pubmed/23152702
http://dx.doi.org/10.2147/CMAR.S27593
work_keys_str_mv AT mawhinneymarkr currenttreatmentoptionsforthemanagementofesophagealcancer
AT glasgowroberte currenttreatmentoptionsforthemanagementofesophagealcancer